Search clinical trials for: 68Ga-R11228

Total 748 results

Radionetics Oncology

Terminated

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer | Metastatic Hormone Receptor Positive Breast Cancer

United States, Australia
Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Completed

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Neuroendocrine Neoplasms

Japan
Peking Union Medical College Hospital

Recruiting

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

Multiple Myeloma

China
Pentixapharm AG

Terminated

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

CNS Lymphoma

Denmark, France
First Affiliated Hospital of Fujian Medical University

Recruiting

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Lymphoma | Leukemia | Multiple Myeloma

China

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe